Published in Transl Res on June 18, 2014
Systemic and renal lipids in kidney disease development and progression. Am J Physiol Renal Physiol (2015) 0.77
Nephrotic syndrome: what's new, what's hot? Korean J Pediatr (2015) 0.76
Novel therapeutic approaches for chronic kidney disease due to glomerular disorders. Am J Physiol Renal Physiol (2016) 0.75
Role of albumin and its modifications in glomerular injury. Pflugers Arch (2017) 0.75
Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL. Nat Genet (2007) 13.78
NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet (2000) 7.98
Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene. J Biol Chem (2000) 4.15
Peroxisome proliferator-activated receptor gamma target gene encoding a novel angiopoietin-related protein associated with adipose differentiation. Mol Cell Biol (2000) 3.60
Circulating angiopoietin-like 4 links proteinuria with hypertriglyceridemia in nephrotic syndrome. Nat Med (2013) 2.41
Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome. Nat Med (2010) 2.32
Neph1 and nephrin interaction in the slit diaphragm is an important determinant of glomerular permeability. J Clin Invest (2003) 2.06
Genetic variation in ANGPTL4 provides insights into protein processing and function. J Biol Chem (2009) 1.64
Muscle-derived angiopoietin-like protein 4 is induced by fatty acids via peroxisome proliferator-activated receptor (PPAR)-delta and is of metabolic relevance in humans. Diabetes (2008) 1.48
Angiopoietin-like 4 (ANGPTL4, fasting-induced adipose factor) is a direct glucocorticoid receptor target and participates in glucocorticoid-regulated triglyceride metabolism. J Biol Chem (2009) 1.45
Caloric restriction and exercise increase plasma ANGPTL4 levels in humans via elevated free fatty acids. Arterioscler Thromb Vasc Biol (2009) 1.36
ZHX proteins regulate podocyte gene expression during the development of nephrotic syndrome. J Biol Chem (2006) 1.31
New insights into human minimal change disease: lessons from animal models. Am J Kidney Dis (2011) 1.18
Induction of cardiac Angptl4 by dietary fatty acids is mediated by peroxisome proliferator-activated receptor beta/delta and protects against fatty acid-induced oxidative stress. Circ Res (2010) 1.18
Molecular mechanisms of lipid disorders in nephrotic syndrome. Kidney Int (2003) 1.13
Characterization of cationic albumin in minimal change nephropathy. Kidney Int (1987) 1.02
Angiopoietin-like 4 based therapeutics for proteinuria and kidney disease. Front Pharmacol (2014) 0.98
Glomerular disease: looking beyond pathology. Clin J Am Soc Nephrol (2014) 0.86
Edema in the nephrotic syndrome: new aspect of an old enigma. J Am Soc Nephrol (2003) 0.84
Telomerase at the center of collapsing glomerulopathy. Nat Med (2012) 0.78
Nephrotic syndrome: components, connections, and angiopoietin-like 4-related therapeutics. J Am Soc Nephrol (2014) 0.96